Sign in

CIK 0001735438

  • Non-accelerated filer
  • Smaller reporting company

MeiraGTx Holdings plc

Sign in to watch
Ticker
MGTX
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Entity type
Operating
EIN
981448305
Phone
+1 646-860-7985
Business address
655 THIRD AVENUE, SUITE 1115, NEW YORK, NY, 10017
  1. 4 Open-market sale Chief Development Officer sold 12,000 shares at $17.95 ($215,400)
  2. 4 Open-market sale Chief Development Officer sold 9,390 shares at $15.06 ($141,413)
  3. 4 Open-market sale Chief Development Officer sold 2,610 shares at $15.04 ($39,254)
  4. 4 Derivatives Options or other derivatives
  5. 4 Derivatives Options or other derivatives
  6. 4 Derivatives Options or other derivatives
  7. 4 Derivatives Options or other derivatives
  8. 4 Derivatives Options or other derivatives
  9. 4 Derivatives Options or other derivatives
  10. 4 Derivatives Options or other derivatives
  11. 4 Derivatives Options or other derivatives
  12. 4 Derivatives Options or other derivatives
  13. 4 Open-market sale President and CEO sold 30,000 shares at an average $15.02 ($450,740)
  14. 4 Open-market sale Chief Development Officer sold 6,082 shares at an average $15.01 ($91,301)
  15. 4/A Open-market sale Chief Development Officer sold 5,918 shares at an average $15.10 ($89,334)
  16. 4 Open-market sale Chief Development Officer sold 5,177 shares at an average $15.11 ($78,211)
  17. 4 Exercise or conversion Director acquired 12,882 shares (option exercise)
  18. 4 Open-market sale President and CEO sold 30,000 shares at an average $15.59 ($467,550)
  19. 4 Derivatives Options or other derivatives
  20. 4 Derivatives Options or other derivatives

Page 9 of 13 · 260 filings